EAHP COVID-19 Resource Centre | Healthcare Professionals Associations

Alzheimer Europe

  • Resource Hub
    Alzheimer Europe has put together a range of valuable online resources with helpful information, tips and guidelines.

American Association for the Study of Leaver Diseases

American Society for Parenteral and Enteral Nutrition (ASPEN)

American Society of Consultant Pharmacists

American Society of Health-System Pharmacist (ASHP)

  • Assessment of Evidence for COVID-19-Related Treatments
    The information contained in this evidence table is emerging and rapidly evolving because of ongoing research and is subject to the professional judgment and interpre- tation of the practitioner due to the uniqueness of each medical facility’s approach to the care of patients with COVID-19 and the needs of individual patients.
  • Assessment of Evidence for COVID-19-Related Treatments
    The table contains emerging and rapidly evolving information on COVID-19 treatment options. Selected entries were updated on 17 April 2020.
  • Interactive Handbook on Injectable Drugs
    ASHP has put together a multiple drug compatibility search feature which is designed to facilitate searching for compatibility information on a number of two-drug or drug-solution combination at one time. The handbook can be accessed for free through 15 May. 

American Thoracic Society

Association of Anesthetists

  • COVID-19 potential anaesthetic drug list
    The Association of Anaesthetists and the Royal College of Anaesthetists have produced guidance which summarises potential miti-gations to be used in the management of such demand.

Association of British Neurologists

Austrian Society of Pneumology (ÖGP)

Belgian Pharmaceutical Association (APB)

Belgian Society of Intensive Care Medicine

British Association of Dermatology (BAD)

British Geriatrics Society (BGS)

British Society of Gastroenterology (BSG)

British Society of Paediatric Gastroenterology, Hepatology and Nutrition

British Thoracic Society (BTS)

Canadian Pharmacists Association

Canadian Society of Hospital Pharmacists

  • COVID-19: What Pharmacists Know Now
    The webinar series shares information on hospital pharmacists' knowledge linked to different aspects that healthcare professionals can encounter in their hospitals.

Canadian Society of Otolaryngology-Head & Neck Surgery

Chinese Pharmaceutical Association

China Law Translate

  • Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Provisional 7th Edition) | An unofficial translation of the Chinese guidelines
    The content outlines the Chinese guidelines for COVID-19 including pathogenic and epidemiological characteristics, pathological changes and clinical characteristics. The webpage also includes the diagnostic criteria and the clinical classifications for the mild form, regular form, severe form and critical form in adults and children and the clinical warning signs. Furthermore, the guideline includes recommendations for treatment and the criteria for discharge and discharge notes as well as infection control.

Dutch Association of Hospital Pharmacists (NVZA)

  • Preparation of disinfectant for hand hygiene
    Paul Le Brun and Kirsten Schimmel, two Dutch hospital pharmacists, have put together information on the preparation of disinfectant for hand hygiene. The formulation was defined by the Dutch Laboratory of Pharmacists and has been translated into English. 
  • !ONLY FOR NVZA MEMBERS! COVID-19 resources
    NVZA has put together COVID-19 related information for its members. The information can be accessed by members through NVZA Connect.
  • National Medicines Coordination Center Newsroom
    The latest COVID-19 news is shared by the National Medicines Coordination Center which is supported by NVZA.

Dutch Federation of Medical Specialists

ENT UK (Ear, Nose and Throat surgery)

European Academy of Dermatology and Venereology (EADV)

  • EADV Task Force Recommendations
    EADV provided experts recommendations related to different fields of dermatology and venereology, which serve as resources for dermatologists and their patients during the COVID-19 episode.

European Association for the Study of the Liver

European Hematology Association (EHA)

European Pain Federation (EFIC)

  • COVID-19 resources
    The EFIC COVID-19 Task Force has put together recent research on COVID-19 with regards to pain treatment of patients. 

European Psychiatric Association

European Society for Blood and Marrow Transplantation

European Society for Medical Oncology (ESMO)

European Society of Cardiology (ESC)

European Society of Intensive Care Medicine (ESICM)

French-Language Society of Pneumology (SPLF)

French Resuscitation Society (SRLF)

  • Expert recommendations for the resuscitative management of patients during an outbreak of CoV2-CoVRSA | Recommandations d'experts portant sur la prise en charge en réanimation des patients en période d'épidémie à SARS-CoV2
    SRLF has made available recommendations for the resuscitative management of patients. Page 11 of the document lists specific treatment options for COVID-19, including recommendations for Remdesivir, Lopinavir/ritonavir; Chloroquine, Anticorps monoclonaux and Umifenovir. Molecules under evaluation include: Favipiravir, Nitazoxanide, Niclosamide, Prulifloxacin, Bictegravir, Nelfinavir, Tegobuvi and Atazanavir.

French Society of Anaesthesia & Intensive Care Medicine (SFAR)

French Society of Clinical Pharmacy (SFPC)

  • Useful Resources to Fight COVID-19 | Documents utiles à la prise en charge du COVID-19
    The French Society of Clinical Pharmacy (SFPC) has made available information linked to the good use of medicines and therapeutic care in their resource centre. The information is only available in French.

French Society of Oncological Pharmacy (Société Francaise de Pharmacie Oncologique-SFPO)

French Society of Pharmacology and Therapeutics

Geneva University Hospitals

German Association of Hospital Pharmacists (ADKA)

  • !ONLY FOR ADKA MEMBERS! COVID-19 resources
    ADKA has put together COVID-19 related information for its members. The information can be accessed by members through login into their dedicated account on the ADKA website.

German Society for Palliative Medicine

Group of Belgian professional medical specialist

IDstewardship.com

  • Coronavirus (COVID-19) Resources For Pharmacists
    IDstewardship.com has created a webpage to provide insights and resources for pharmacists to help them manage the COVID-19 pandemic. The webpage lists general resources, treatment guidelines, including information on Remdesivir, Lopinavir/ritonavir (Kaletra, LPV/r), Chloroquine, Hydroxychloroquine (Plaquenil) and Tocilizumab (Actemra).

Interacciones VIH

  • COVID-19 Lopinavir/ritonavir (LPV/r), hydroxychloroquine (HCQ) and remdesivir (RDV): main interactions | COVID‐19 Lopinavir/ritonavir (LPV/r), hidroxicloroquina (HCQ) y remdesivir (RDV): principales interacciones  
    The Hospital Clínic de Barcelona has made available a table summarizing the most relevant interactions with current recommended treatments for COVID-19 and other common drugs COVID-19 Lopinavir / ritonavir (LPV/r) and hydroxychloroquine (HCQ), including main contraindicated or not recommended associations and data with other commonly used drugs.

International Union of Basic and Clinical Pharmacology (IUPHAR) / British Pharmacological Society (BPS)

  • Guide to pharmacology
    The Guide to Pharmacology (GtoPdb) curation team has gathered information from various sources to cover as many of the pharmacological strategies currently being considered. The information on this page is curated and updated by the GtoPdb curation team at the University of Edinburgh.

Italian Hospital Pharmacists

  • COVID-19 Bulletin UMPC in Italy of 12 March 2020 | COVID-19 Bulletin UMPC in Italy 12 marzo 2020
    The UPMC bulletin contains links to official information sources and details on how UPMC Italy is managing the situation.
  • COVID-19 treatment guideline | COVID-19 linee guida trattamento
    The diagram contains information on treatment options for COVID-19 taking also into account the severity index and the different therapies for the pneumonia associated with COVID-19.
  • Method of use of Tocilizumab in patients with Covid-19 | Modalità di impiego di Tocilizumab nei pazienti con COVID-19
    This guideline recommends that only patients with a high interleukin-6 value should be treated with Tocilizumab. The recommended treatment of cytokine release syndrome by intravenous infusion lasting 60 minutes and is equal to 4-8 mg/kg in patients weighing more than 30kg. Doses above 800mg per infusion are not recommended.

Italian League Against Epilepsy

Italian Society of Hospital Pharmacy (SIFO)

Italian Society of Infectious and Tropical Diseases (SIMIT)

Italian Society of Pharmacists Responsible for Preparing Medicines (SIFAP)

KU Leuven

Liverpool Drug Interaction Group of the University of Liverpool, UK

  • Prescription resources and interactions of drugs with COVID-19
    The Liverpool Drug Interaction Group, in collaboration with the University Hospital of Basel (Switzerland) and the Radboud UMC (Netherlands), has produced various materials in PDF format to aid the use of experimental agents in the treatment of COVID-19. The site is regularly updated.

Michigan Medicine - University of Michigan (USA)

National Comprehensive Cancer Network

National Health Service (NHS) Specialist Pharmacy Service

Northern Health Physicians

Ordre National des Pharmaciens | National Order of Pharmacists

  • COVID-19 Resource Centre
    The French Order of Pharmacists has put together reference information and communication tools for pharmacists.

Paediatric Intensive Care Society (PICS)

Pisa University Hospital (Azienda Ospedaliero Universitaria Pisana)

Portuguese Order of Pharmacists

Portuguese Pulmonology Society (SPP)

Primary Care Pharmacy Association (PCPA)

  • PCPA COVID-19 hub
    Primary Care Pharmacy COVID-19 Hub compiles resources and information relevant to pharmacy professionals.

Royal College of Cardiologist

Royal College of Obstetricians and Gynaecologists

  • Coronavirus (COVID-19) infection and pregnancy
    The Royal College of Obstetricians and Gynaecologists has made available information, including guidance for healthcare professionals on COVID-19 infection in pregnancy, published by the RCOG, Royal College of Midwives, Royal College of Paediatrics and Child Health, Public Health England and Health Protection Scotland.

Royal College of Paediatrics and Child Health

Royal College Of Psychiatrists

Royal Pharmaceutical Society / Pharmaceutical Press

Sciensano

  • Interim clinical guidance for adults with suspected or confirmed COVID-19 in Belgium (Version 6)
    Sciensano has published a guideline that summarises the selected investigational drugs to consider for clinical use at this moment in Belgium, with information on in vitro/in vivo efficacy; the current therapeutic recommendations for each category of COVID-19 patients, with indications and precautions; and the treatment protocols that are in use in some other European countries, as obtained at the beginning of March 2020.

Scottish Drug Forum

Society of Surgical Oncology

Spanish Delegation of the Institute for Safe Medication Practices

Spanish Paediatric Association

Spanish Society of Cardiology

Spanish Society of Geriatrics and Gerontology (SEGG)

Spanish Society of Hospital Pharmacy (SEFH)

Spanish Society for Palliative Care

Spanish Society of Thrombosis and Hemostasis

Thrombosis UK

UK: Clinical Pharmacy Association (UKCPA)

UMC Utrecht

  • COVID-19: What do we know about the treatment options | COVID-19: Wat weten we van de therapeutische opties?
    The presentation prepared by hospital pharmacists Emilie Gieling, in collaboration with Prof Dr David Burger from the Radboud UMC details known information about the treatment options of COVID-19. The document is only available in Dutch.

University of Birmingham

  • COVID-19 research briefing
    Researchers across Birmingham Health Partners are collaborating to produce regular COVID-19 briefings based on the latest literature to support clinical colleagues and disseminate key information.

VASCERN - European Reference Network for rare vascular diseases

Vehbi Koc Foundation Healthcare Group

  • COVID-19 experiences
    The Vehbi Koc Foundation Healthcare Group has put together its learnings during the COVID-19 pandemic.  

 

The disclaimer for the EAHP COVID-19 Resource Centre can be found here

Last update: 9 July 2020